Who invested in Sitari Pharmaceuticals?
Sitari Pharmaceuticals's investors include Avalon Ventures and GlaxoSmithKline.
United States · Series A startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2013, from 1 source
Sitari Pharmaceuticals's investors include Avalon Ventures and GlaxoSmithKline.
Sitari Pharmaceuticals has raised $10M across 1 round since 2013.
Sitari Pharmaceuticals's most recent round was a Series A of $10M in Nov 2013.
Its most recent round, $10M in Nov 2013, is also its largest on record.
Sitari Pharmaceuticals's first round on record, in Nov 2013, was backed by Avalon Ventures and GlaxoSmithKline.
Sitari Pharmaceuticals's latest named round is a Series A, in Nov 2013.
Sitari Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.